Antitrust & Competition Life Sciences Quarterly Update - Q1 2023 | Goodwin
Our prior updates covered how FTC enforcement activity largely proceeded “as usual” during 2022 in the life sciences industry, with large pharmaceutical players buying or licensing...
Source: jdsupra.com